Fingerprint CD34 immunopositivity to distinguish neurofibroma from an early/paucicellular desmoplastic melanoma can be misleading

J Cutan Pathol. 2013 Nov;40(11):985-7. doi: 10.1111/cup.12206. Epub 2013 Aug 27.

Authors

Sameera Husain¹, David N Silvers

Affiliation

¹ Division of Dermatopathology, Department of Dermatology, Columbia University, New York, NY, 10032, USA. sh28@columbia.edu.

PMID: 24033860
DOI: 10.1111/cup.12206

No abstract available

Keywords: early/paucicellular desmoplastic melanoma; fingerprint CD34 immunopositivity; neurofibroma.

Publication types

Letter
Comment

MeSH terms

Antigens, CD34 / metabolism*
Humans
Melanoma / diagnosis*
Neurofibroma / diagnosis*
Skin Neoplasms / diagnosis*

Substances

Antigens, CD34